Clinical Trial Update: Real World Evidence of Tivozanib as First-line Treatment for Metastatic Clear Cell Renal Cell Carcinoma

View source ↗

Summary

This completed study reports real-world evidence on using tivozanib as first-line therapy for metastatic clear cell renal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Clear Cell Renal Cell Carcinoma
• Renal Cell Carcinoma

Drugs mentioned

• FOTIVDA (tivozanib)

Snippet

Sponsor: Spanish Oncology Genito-Urinary Group | Conditions: Renal Cell Cancer Metastatic | Status: COMPLETED